Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 3, 2023

CLINICAL TRIALS PROFILE FOR SEROMYCIN

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

All Clinical Trials for Seromycin

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00182000 ↗	Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy	Completed	Hartford Hospital	Phase 3	2003-11-01	This study will assess the effectiveness of Seromycin (D-cycloserine) in enhancing the positive effects of behavior therapy for people with Obsessive-Compulsive Disorder (OCD).
NCT00182000 ↗	Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy	Completed	Massachusetts General Hospital	Phase 3	2003-11-01	This study will assess the effectiveness of Seromycin (D-cycloserine) in enhancing the positive effects of behavior therapy for people with Obsessive-Compulsive Disorder (OCD).
NCT00198120 ↗	Safety and Effectiveness of D-Cycloserine in Children With Autism	Completed	Indiana University School of Medicine	Phase 3	2004-02-01	This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
NCT00198120 ↗	Safety and Effectiveness of D-Cycloserine in Children With Autism	Completed	National Alliance for Research on Schizophrenia and Depression	Phase 3	2004-02-01	This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
NCT00198120 ↗	Safety and Effectiveness of D-Cycloserine in Children With Autism	Completed	National Institute of Mental Health (NIMH)	Phase 3	2004-02-01	This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
NCT00198120 ↗	Safety and Effectiveness of D-Cycloserine in Children With Autism	Completed	Indiana University	Phase 3	2004-02-01	This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Seromycin

Condition Name

Chart
Table

Condition Name for Seromycin
Intervention	Trials
Obsessive-compulsive Disorder	4
Schizophrenia	3
Major Depressive Disorder	3
Posttraumatic Stress Disorder	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Seromycin
Intervention	Trials
Disease	7
Depressive Disorder	4
Stress Disorders, Post-Traumatic	4
Depression	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Seromycin

Trials by Country

Map
Table

Trials by Country for Seromycin
Location	Trials
United States	26
Canada	6
Israel	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Seromycin
Location	Trials
Massachusetts	5
Illinois	2
Georgia	2
Texas	2
Florida	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Seromycin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Seromycin
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	4
Phase 2	12
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Seromycin
Clinical Trial Phase	Trials
Completed	19
Unknown status	4
Recruiting	2
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Seromycin

Sponsor Name

Chart
Table

Sponsor Name for Seromycin
Sponsor	Trials
National Institute of Mental Health (NIMH)	5
University of Calgary	5
Massachusetts General Hospital	4
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Seromycin
Sponsor	Trials
Other	46
NIH	9
U.S. Fed	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Boehringer Ingelheim

McKinsey

Dow

Merck

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.